“Complementary Medicine”的搜索结果，显示 371-380 项，共有 10673 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The main questions the study aims to answer in Phase/Part 1 of the trial are: Is [Ac225]RTX-2358 tolerable or does it cause toxicities (medical problems) in ...

2. 心血管医学- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the impact of pulse electromagnetic field (PEMF) therapy using the Bioboosti device (Biomobie Regenerative Medicine ...

3. 膀胱结石- 症状与病因- 妙佑医疗国际

   Hosseinkhani A, et al. Urinary bladder stone passing using a Persian herbal recipe. Journal of Evidence-Based Integrative Medicine. 2018;23:1. Curhan GC, et ...

4. 心血管医学- 临床试验- 妙佑医疗国际

   ... alternative OAP agents, carrying out that descriptive comparison through discharge. ... therapies to terminate ventricular arrhythmias. A ... This study will be a ...

5. 联邦民权公告多语种版本- 妙佑医疗国际

   humanities-in-medicine. Collapse humanities-in-medicine. arizona · florida · minnesota · education · contact · 为就诊做准备. Collapse 为就诊做准备. 您的打包清单 ...

6. 血管母细胞瘤- 症状与病因- 妙佑医疗国际

   Understanding integrative (holistic) medicine. American Cancer Society. https://www.cancer.org/cancer/supportive-care/integrative-medicine.html. Accessed ...

7. 普通内科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine whether serum biomarkers and comorbidities differ between subjects with hEDS/HSD vs. other non-hypermobile EDS ...

8. 普通内科 - 临床试验 - 妙佑医疗国际

   The purpose of this study is to determine whether serum biomarkers and comorbidities differ between subjects with hEDS/HSD vs. other non-hypermobile EDS ...

9. 肾病和高血压- 临床试验- 妙佑医疗国际

   Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD. Accurate, MR based kidney volume measurements are the ...

10. 临床试验- 检验医学与病理学- 妙佑医疗国际

    ... medical records now and in the future. The Biobank serves as a library for researchers; instead of having to look for volunteers for each new project ...